Severe and Prolonged Lymphopenia Observed in Patients Treated With Bendamustine and Erlotinib for Metastatic Triple Negative Breast Cancer

Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-013-2112-2

Related search